Novo Nordisk shares tumble as data on weight-loss drug trial disappoints
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Novo Nordisk’s...
tumble
Eli Lilly shares tumble as company’s weight-loss drug misses Wall Street sales expectations
Open this photo in gallery:The Eli Lilly & Co. corporate headquarters, in Indianapolis, on April 26, 2017.Darron Cummings/The Associated PressEli...
